肝脂肪變性分析試劑盒 | 貨號K584-100

Only Kit on the market to use a dual method to study Hepatic Steatosis: Quantifies Triglycerides (colorimetric/fluorometric) and visualizes lipid droplets by staining with Oil Red O.

產品介紹: 肝脂肪變性也稱為脂肪肝，是一種以肝臟內脂滴過度積聚為特徵的疾病。 這可能是由多種因素造成的，包括過量飲酒，肥胖以及其他脂肪代謝異常的疾病。 肝脂肪變性通常用作確定候選藥物肝毒性的標誌物。 BioVision的肝脂肪變性試劑盒提供用於測量細胞內甘油三酯積累的試劑和染色試劑以可視化肝細胞中的脂滴形成。 該試劑盒可用於篩选和評估候選藥物的脂肪變性風險，並研究脂肪變性發展的機制。 包括氯喹作為誘導肝細胞如HepG2脂肪變性的陽性對照。 該試劑盒提供足夠的試劑用於甘油三酯定量的100個測定和足夠用於兩個96孔板，兩個6孔板或四個100mm培養皿的染色試劑。

Cat # +Size	K584-100
Size	100 assays
Detection Method	Absorbance (OD 570 nm) or Fluorescence (Ex/Em = 535/587 nm) and Microscopy
Species Reactivity	Mammalian
Applications	Evaluate hepatic steatosis, quantify triglycerides, and visualize lipid droplet accumulation Screen drug candidates for steatotic risk
Features & Benefits	• Only Kit on the market to use a dual method to study Hepatic Steatosis: Quantifies Triglycerides (colorimetric/fluorometric) and visualizes lipid droplets by staining with Oil Red O. • The kit provides enough reagents for 100 assays for triglyceride quantitation and staining reagents enough for two 96-well plates, two 6-well plates, or four 100 mm culture dishes. • Easy and simple protocol. This kit can be used to screen and evaluate steatosis risk of drug candidates and to study the mechanism of steatosis development. • Chloroquine is included as a positive control for inducing steatosis in liver cells, such as HepG2.
Kit Components	• Triglyceride Assay Buffer • Triglyceride Probe (in DMSO) • Lipase • Triglyceride Enzyme Mix • Triglyceride Standard (1 mM) • Chloroquine • PBS • Formalin (10%) • Oil Red O • Methyl Green

 

  前脂肪細胞分離試劑盒 | 甘油三酯（TG）螢光檢測-384well | 三酸甘油酯呈色/螢光分析 | 肝脂肪變性分析試劑盒